跳至主要内容
临床试验/NCT03813121
NCT03813121已完成1 期

The Effects of Sedatives on Tobacco Use Disorder

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2019年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
1
主要终点
Side Effects

研究概览

简要总结

This proposal will obtain preliminary data on the effect of a single sub-anesthetic dose of a sedative on cigarette craving and smoking behavior as well as measuring tolerability and acceptability.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

盲法说明

single-blind

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • smoke at least 5 cigarettes per day
  • smoked at least 2 years
  • negative urine drug screen for psychoactive drugs and negative breath alcohol concentration
  • live in Little Rock AR or surrounding area

排除标准

  • unstable or stable medical condition that would interact with study medication or participation
  • serious head trauma or neurological disorder
  • hypertension, abnormal ECG or metabolic blood results
  • meet criteria for psychosis, schizophrenia, major depressive disorder, or bipolar disorder
  • use of psychoactive drugs or medications
  • BMI > 40
  • among women, pregnancy or breastfeeding

研究组 & 干预措施

ketamine intravenous infusion

Experimental

single ketamine infusion (0.5 mg/kg over 20 minutes)

干预措施: ketamine intravenous infusion (Drug)

midazolam intravenous infusion

Experimental

single midazolam infusion (0.02 mg/kg over 20 minutes)

干预措施: midazolam intravenous infusion (Drug)

placebo intravenous infusion

Placebo Comparator

single placebo infusion (saline over 20 minutes)

干预措施: placebo intravenous infusion (Drug)

结局指标

主要结局

Side Effects

时间窗: about 1 week post infusion

drug side effects scale: severity scale from 1 (not at all) to 7 (extremely) for symptoms of nausea, dizziness, sleepiness, strange thoughts, hallucinations, confusion, anxiousness, and headache. The average score across all side effects is reported.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验